Pancreatic expression of interferon-γ protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis

[1]  R. Hruban,et al.  The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. , 1999, Medicine.

[2]  A. Ramsingh,et al.  T Cells Contribute to Disease Severity during Coxsackievirus B4 Infection , 1999, Journal of Virology.

[3]  M. Martone,et al.  Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy , 1999, Nature Medicine.

[4]  N. Sarvetnick,et al.  Protection from Lethal Coxsackievirus-Induced Pancreatitis by Expression of Gamma Interferon , 1999, Journal of Virology.

[5]  C. Lowenstein,et al.  An Antiviral Mechanism of Nitric Oxide , 1999, Immunity.

[6]  T. Treasure,et al.  Meta-analysis of the association of enteroviruses with human heart disease , 1997, Heart.

[7]  Moses Rodriguez,et al.  Primary demyelination in transgenic mice expressing interferon-γ , 1997, Nature Medicine.

[8]  S. Hill,et al.  The pathogenesis of postinfectious myocarditis. , 1996, Clinical immunology and immunopathology.

[9]  C. Lowenstein,et al.  Nitric oxide inhibits viral replication in murine myocarditis. , 1996, The Journal of clinical investigation.

[10]  J. Whitton,et al.  The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis , 1995, Journal of virology.

[11]  P. Hofschneider,et al.  Investigation of the coxsackievirus B3 nonstructural proteins 2B, 2C, and 3AB: generation of specific polyclonal antisera and detection of replicating virus in infected tissue. , 1994, Journal of virological methods.

[12]  T. Martino,et al.  Viral infection and the pathogenesis of dilated cardiomyopathy. , 1994, Circulation research.

[13]  S. Tracy,et al.  Epitopes shared between coxsackievirus B3 (CVB3) and normal heart tissue contribute to CVB3-induced murine myocarditis. , 1993, Clinical immunology and immunopathology.

[14]  B. McManus,et al.  Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. , 1993, Clinical immunology and immunopathology.

[15]  N. Sarvetnick,et al.  Epithelial cell proliferation and islet neogenesis in IFN-g transgenic mice. , 1993, Development.

[16]  C. Gauntt,et al.  Anti-Coxsackievirus B3 neutralizing antibodies with pathological potential. , 1991, European heart journal.

[17]  N. Sarvetnick,et al.  Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma , 1988, Cell.

[18]  K. Beisel,et al.  Postinfectious Autoimmunity: Two Distinct Phases of Coxsackievirus B3‐Induced Myocarditis a , 1986, Annals of the New York Academy of Sciences.

[19]  K. Beisel,et al.  Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis , 1985, The Journal of experimental medicine.

[20]  Y. Cao,et al.  Coxsackievirus B3 persistence and myocarditis in N:NIH(S) II nu/nu and +/nu mice. , 1984, The Journal of general virology.

[21]  M. Tatsumi,et al.  The role of T lymphocytes in the pathogenesis of Coxsackie virus B3 heart disease. , 1983, British journal of experimental pathology.

[22]  J. Melnick,et al.  The histopathology of Coxsackie virus infection in mice. I. Morphologic observations with four different viral types. , 1952, The American journal of pathology.

[23]  W. Mckenna,et al.  Coxsackie B viruses and human heart disease. , 1997, Current topics in microbiology and immunology.

[24]  B. McManus,et al.  Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. , 1992, Laboratory investigation; a journal of technical methods and pathology.